The 11S regulators of 20S proteasome activity

Current Topics in Microbiology and Immunology

Volumn 268, Issue , 2002, Pages 73-89

  Hill, C P ^a   Masters, E I ^a   Whitby, F G ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OLIGOMER; PROTEASOME; UBIQUITIN;

CRYSTAL STRUCTURE; ENZYME ACTIVE SITE; ENZYME SUBUNIT; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FOLDING; REVIEW; STOICHIOMETRY;

EID: 0036092457     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-642-59414-4_4     Document Type: Review

References (94)

1. Primary structures of two homologous subunits of PA28. a γ-interferon-inducible protein activator of the 20S proteasome
2. In vivo characterization of the proteasome regulator PA28
3. Processive degradation of proteins and other catalytic properties of the proteasome from Thermoplasma acidophilum
4. Interferon-γ can stimulate post-proteasomal trimming of the N-terminus of an antigenic peptide by inducing leucine aminopeptidase
5. At sixes and sevens: Characterization of the symmetry mismatch of the ClpAP chaperone-assisted protease
6. Subcellular localization of proteasomes and their regulatory complexes in mammalian cells
7. Two distinct proteolytic processes in the generation of a major histocompatibility class I presented peptide
8. The proteasome, a novel protease regulated by multiple mechanisms
9. Degradation of oxidized insulin B chain by the multiproteinase complex macropain (proteasome)
10. Contribution of proteasomal beta-subunits to the cleavage of peptide substrates analyzed with yeast mutants
11. Coordinated dual cleavages induced by the proteasome regulator PA28 lead to dominant MHC ligands
12. Decelerated degradation of short peptides by the 20S proteasome
13. MHC-linked LMP gene products specifically alter peptidase activities of the proteasome
14. Purification of an 11S regulator of the multicatalytic protease
15. Bovine spleen multicatalytic proteinase complex (proteasome). Replacement of X, Y, and Z subunits by LMP7, LMP2, and MECL1 and changes in properties and specificity
16. Processing of major histocompatibility class 1-restricted antigens in the endoplasmic reticulum
17. Structure of peptides associated with MHC class 1 molecules
18. Activity and regulation of the centrosome-associated proteasome
19. Antigen presentation by MHC class 1 and its regulation by interferon gamma
20. Proteasome subunits X and Y alter peptidase activities in opposite ways to the interferon-y-induced subunits LMP2 and LMP7
21. γ-interferon and expression of MHC genes regulate peptide hydrolysis by proteasomes
22. PA28 activator protein forms regulatory caps on proteasome stacked rings
23. A role for the proteasome regulator PA28α in antigen presentation
24. Peptide antigen production by the proteasome: Complexity provides efficiency
25. A gated channel into the proteasome core particle
26. Structure of 20S proteasome from yeast at 2.4Å resolution
27. Simultaneous binding of PA28 and PA700 activators to 20S proteasomes
28. Regulatory features of multicatalytic and 26S proteases
29. Sequence and expression of mouse proteasome activator PA28 and the related autoantigen Ki
30. The proteasome 11S regulator subunit REGα (PA28α) is a heptamer
31. Interaction between the protein kinase B-Raf and the alpha-subunit of the 11S proteasome regulator
32. PA28 subunits of the mouse protea-some: Primary structures and chromosomal localization of the genes
33. Proteasome active sites allosterically regulate each other, suggesting a cyclical bite-chew mechanism for protein breakdown
34. Range of sizes of peptide products generated during degradation of different proteins by archaeal proteasomes
35. The sizes of peptides generated from protein by mammalian 26 and 20S proteasomes. Implications for understanding the degradative mechanism and antigen presentation
36. The role of the proteasome system and the proteasome activator PA28 complex in the cellular immune response
37. Structure of the proteasome activator REGa (PA28a)
38. Proteasome activator PA28 and its interaction with 20S proteasomes
39. Reconstitution of proteasome activator PA28 from isolated subunits: Optimal activity is associated with an alpha,beta-heteromultimer
40. Structural and functional properties of proteasome activator PA28
41. The proteasome activator 11S REG or PA28: Chimeras implicate carboxyl-terminal sequences in oligomerization and proteasome binding but not in the activation of specific proteasome catalytic subunits
42. Phosphorylation of the proteasome activator PA28 is required for proteasome activation
43. Bifunctional inhibitors of the trypsin-like activity of eukaryotic proteasomes
44. Crystal structure of the 20S proteasome from the archaeon T. acidophilum at 3.4Å resolution
45. Identification, purification, and characterization of a protein activator (PA28) of the 20S proteasome (macropain)
46. PA28, an activator of the 20S proteasome, is inactivated by proteolytic modification at its carboxyl terminus
47. Dendritic cells up-regulate immunoproteasomes and the proteasome regulator PA28 during maturation
48. Invasion by Salmonella typhimurium induces increased expression of the LMP, MECL, and PA28 proteasome genes and changes in the peptide repertoire of HLA-B27
49. A critical role for the proteasome activator PA28 in the Hsp90-dependent protein refolding
50. PA28, an activator of the 20S proteasome, is composed of two nonidentical but homologous subunits
51. Growth retardation in mice lacking the proteasome activator PA28γ
52. Differential effects of bovine PA28 on six peptidase activities of the lobster muscle proteasome (multicatalytic proteinase)
53. Potential immunocompetence of proteolytic fragments produced by proteasomes before evolution of the vertebrate immune system
54. The proteolytic fragments generated by vertebrate proteasomes: Structural relationships to major histocompatibility complex class 1 binding peptides
55. Cloning and nucleotide sequence of cDNA for Ki antigen, a highly conserved nuclear protein detected with sera from patients with systemic lupus erythematosus
56. Cleavage motifs of the yeast 20S proteasome beta subunits deduced from digests of enolase 1
57. Chronic contractile activity upregulates the proteasome system in rabbit skeletal muscle
58. A tick homolog of the human Ki nuclear autoantigen
59. Mechanisms of MHC class 1 - Restricted antigen processing
60. Impaired immunoproteasome assembly and immune responses in PA28-/- mice
61. Peptides naturally presented by MHC class I molecules
62. Molecular cloning and expression of a gamma-interferon inducible activator of the multicatalytic protease
63. Characterization of recombinant REGα, REGβ and REGγ proteasome activators
64. A proteasome activator subunit binds calcium
65. KEKE motifs: Proposed roles in protein-protein association and presentation of peptides by MHC class I receptors
66. The proteasome activator 11S REG (PA28) and class I antigen presentation
67. Degradation of cell proteins and the generation of MHC class I-presented peptides
68. Evidence for the existence of a non-catalytic modifier site of peptide hydrolysis by the 20S proteasome
69. Overexpression of the proteasome subunits LMP2, LMP7, and MECL-1, but not PA28α/β, enhances the presentation of an immunodominant lymphocytic choriomeningitis virus T cell epitope
70. Double-cleavage production of the CTL epitope by proteasomes and PA28: Role of the flanking region
71. Trimming of antigenic peptides in an early secretory compartment
72. A model for the quaternary structure of the proteasome activator PA28
73. Relative functions of the α and β subunits of the proteasome activator, PA28
74. Expression and subcellular localization of mouse 20S proteasome activator complex PA28
75. Antigenic peptide binding by class I and class II histocompatibility proteins
76. Kinetic evidences for facilitation of peptide channelling by the proteasome activator PA28
77. Hybrid proteasomes. Induction by interferon-γ and contribution to ATP-dependent proteolysis
78. Molecular properties of the proteasome activator PA28 family proteins and gamma-interferon regulation
79. The MHC class I ligand-generating system: Roles of immunoproteasomes and the interferon-gamma-inducible proteasome activator PA28
80. Identification and characterization of an activated 20S proteasome in Trypanosoma brucei
81. Precipitating antibody to a soluble nuclear antigen 'Ki' with specificity for systemic lupus erythematosus
82. Effects of interferon γ and major histocompatibility complex-encoded subunits on peptidase activities of human multicatalytic proteases
83. The 26S proteasome: A molecular machine designed for controlled proteolysis
84. Conformational constraints in protein degradation by the 20S proteasome
85. Structural basis for the activation of 20S proteasomes by 11S regulators
86. Dynamic association of proteasomal machinery with the centrosome
87. Proteasome activator (PA28) subunits, alpha, beta and gamma (Ki antigen) in NT2 neuronal precursor cells and HeLa S3 cells
88. Structural and functional characterization of the proteasome-activating protein PA26 from Trypanosoma brucei
89. Cell biology of antigen processing and presentation to major histocompatibility complex class I molecule-restricted T lymphocytes
90. Identification of an activation region in the proteasome activator REGα
91. The proteasome activator or PA28. Contribution by both α and β subunits to proteasome activation
92. Proteasome activator 11S REG or PA28, Recombinant REGα/REGβ hetero-oligomers are heptamers
93. Proteasome activation by REG molecules lacking homolog-specific inserts
94. Subunit topology of the Rhodococcus proteasome